Switzerland Sample Contracts

Gain Therapeutics, Inc.CONSULTING AGREEMENT between (February 19th, 2021)

GT Gain Therapeutics S.A, a Swiss Corporation, with registered office in Via Peri 9D, 6900 Lugano, Switzerland, registration number with the Register of Enterprises of Lugano and Tax Code CHE 438 987 642, represented herein by Mr. Lorenzo Leoni, in his capacity as President (hereinafter referred to as the "Company"),

Ultragenyx Pharmaceutical Inc.Contract (February 12th, 2021)

[***] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED

Philip Morris International Inc.PHILIP MORRIS INTERNATIONAL INC. RESTRICTED STOCK UNIT AGREEMENT FOR PHILIP MORRIS INTERNATIONAL INC. COMMON STOCK (February 4, 2021) (February 9th, 2021)

PHILIP MORRIS INTERNATIONAL INC. (the “Company”), a Virginia corporation, hereby grants to the employee identified in the Award Statement (the “Employee”) under the Philip Morris International Inc. 2017 Performance Incentive Plan (the “Plan”), a Restricted Stock Unit Award (the “Award”) dated February 4, 2021 (the “Award Date”) with respect to the number of shares of the Common Stock of the Company (the “Common Stock”) set forth in the Award Statement (the “RSUs”), all in accordance with and subject to the following terms and conditions:

Philip Morris International Inc.PHILIP MORRIS INTERNATIONAL INC. 2017 PERFORMANCE INCENTIVE PLAN (February 9th, 2021)

PHILIP MORRIS INTERNATIONAL INC. (the “Company”), a Virginia corporation, hereby grants to the employee identified in the Award Statement (the “Employee”) under the Philip Morris International Inc. 2017 Performance Incentive Plan (the “Plan”), a Restricted Stock Unit Award (the “Award”) dated May 1, 2020 (the “Award Date”) with respect to the number of shares of the Common Stock of the Company (the “Common Stock”) set forth in the Award Statement (the “RSUs”), all in accordance with and subject to the following terms and conditions:

Philip Morris International Inc.PHILIP MORRIS INTERNATIONAL INC. PERFORMANCE SHARE UNIT AGREEMENT FOR PHILIP MORRIS INTERNATIONAL INC. COMMON STOCK (February 4, 2021) Performance Period: January 1, 2021 to December 31, 2023 (February 9th, 2021)

PHILIP MORRIS INTERNATIONAL INC. (the “Company”), a Virginia corporation, hereby grants to the employee identified in the Award Statement (the “Employee”) under the Philip Morris International Inc. 2017 Performance Incentive Plan (the “Plan”), a Performance Share Unit Award (the “Award”) dated February 4, 2021 (the “Award Date”) representing a right to receive shares of the Common Stock of the Company (the “Common Stock”) set forth in the Award Statement (the “PSUs”), all in accordance with and subject to the following terms and conditions:

Philip Morris International Inc.PHILIP MORRIS INTERNATIONAL INC. RESTRICTED STOCK UNIT AGREEMENT FOR PHILIP MORRIS INTERNATIONAL INC. COMMON STOCK (February 4, 2021) (February 9th, 2021)

PHILIP MORRIS INTERNATIONAL INC. (the “Company”), a Virginia corporation, hereby grants to the employee identified in the Award Statement (the “Employee”) under the Philip Morris International Inc. 2017 Performance Incentive Plan (the “Plan”), a Restricted Stock Unit Award (the “Award”) dated February 4, 2021 (the “Award Date”) with respect to the number of shares of the Common Stock of the Company (the “Common Stock”) set forth in the Award Statement (the “RSUs”), all in accordance with and subject to the following terms and conditions:

Philip Morris International Inc.PHILIP MORRIS INTERNATIONAL INC. PERFORMANCE SHARE UNIT AGREEMENT FOR PHILIP MORRIS INTERNATIONAL INC. COMMON STOCK (February 4, 2021) Performance Period: January 1, 2021 to December 31, 2023 (February 9th, 2021)

PHILIP MORRIS INTERNATIONAL INC. (the “Company”), a Virginia corporation, hereby grants to the employee identified in the Award Statement (the “Employee”) under the Philip Morris International Inc. 2017 Performance Incentive Plan (the “Plan”), a Performance Share Unit Award (the “Award”) dated February 4, 2021 (the “Award Date”) representing a right to receive shares of the Common Stock of the Company (the “Common Stock”) set forth in the Award Statement (the “PSUs”), all in accordance with and subject to the following terms and conditions:

Philip Morris International Inc.PHILIP MORRIS INTERNATIONAL INC. 2017 PERFORMANCE INCENTIVE PLAN (February 9th, 2021)

PHILIP MORRIS INTERNATIONAL INC. (the “Company”), a Virginia corporation, hereby grants to the employee identified in the Award Statement (the “Employee”) under the Philip Morris International Inc. 2017 Performance Incentive Plan (the “Plan”), a Restricted Stock Unit Award (the “Award”) dated May 1, 2020 (the “Award Date”) with respect to the number of shares of the Common Stock of the Company (the “Common Stock”) set forth in the Award Statement (the “RSUs”), all in accordance with and subject to the following terms and conditions:

Philip Morris International Inc.PHILIP MORRIS INTERNATIONAL INC. 2017 PERFORMANCE INCENTIVE PLAN (February 9th, 2021)

PHILIP MORRIS INTERNATIONAL INC. (the “Company”), a Virginia corporation, hereby grants to the employee identified in the Award Statement (the “Employee”) under the Philip Morris International Inc. 2017 Performance Incentive Plan (the “Plan”), a Performance Share Unit Award (the “Award”) dated May 1, 2020 (the “Award Date”) representing a right to receive shares of the Common Stock of the Company (the “Common Stock”) set forth in the Award Statement (the “PSUs”), all in accordance with and subject to the following terms and conditions:

Philip Morris International Inc.EARLY RETIREMENT AGREEMENT (the “Agreement”) and RELEASE Dear Marc, (February 9th, 2021)

This Agreement sets out the terms that Philip Morris Products S.A. (the “Company”) has agreed with you shall apply to your early retirement.

Philip Morris International Inc.PHILIP MORRIS INTERNATIONAL INC. RESTRICTED STOCK UNIT AGREEMENT FOR PHILIP MORRIS INTERNATIONAL INC. COMMON STOCK (February 4, 2021) (February 9th, 2021)

PHILIP MORRIS INTERNATIONAL INC. (the “Company”), a Virginia corporation, hereby grants to the employee identified in the Award Statement (the “Employee”) under the Philip Morris International Inc. 2017 Performance Incentive Plan (the “Plan”), a Restricted Stock Unit Award (the “Award”) dated February 4, 2021 (the “Award Date”) with respect to the number of shares of the Common Stock of the Company (the “Common Stock”) set forth in the Award Statement (the “RSUs”), all in accordance with and subject to the following terms and conditions:

Philip Morris International Inc.PHILIP MORRIS INTERNATIONAL INC. PERFORMANCE SHARE UNIT AGREEMENT FOR PHILIP MORRIS INTERNATIONAL INC. COMMON STOCK (February 4, 2021) Performance Period: January 1, 2021 to December 31, 2023 (February 9th, 2021)

PHILIP MORRIS INTERNATIONAL INC. (the “Company”), a Virginia corporation, hereby grants to the employee identified in the Award Statement (the “Employee”) under the Philip Morris International Inc. 2017 Performance Incentive Plan (the “Plan”), a Performance Share Unit Award (the “Award”) dated February 4, 2021 (the “Award Date”) representing a right to receive shares of the Common Stock of the Company (the “Common Stock”) set forth in the Award Statement (the “PSUs”), all in accordance with and subject to the following terms and conditions:

Quotient LTDEMPLOYMENT AGREEMENT (February 4th, 2021)
Quotient LTDQUOTIENT LIMITED CHANGE OF CONTROL AGREEMENT (February 4th, 2021)

THIS CHANGE OF CONTROL AGREEMENT (this "Agreement"), is made on this 1st day of February, 2021, by and between QUOTIENT LIMITED, a public no par value limited liability company incorporated in Jersey, Channel Islands, with registered number 109886 (the "Company") and Vittoria Bonasso (the "Employee").

LIMITED USE LICENSE AGREEMENT (February 4th, 2021)

The use of the Deliverables, as defined herein, is exclusively governed by the terms of this limited use license agreement (the “Agreement”), concluded by and between u-blox AG, a Swiss company with its principal place of business at Zürcherstrasse 68, 8800 Thalwil, Switzerland (“u- blox”), and the company or natural person accepting these licensing terms (“Licensee”). Licensee and u-blox are each a “party” and, collectively, are the “parties” to this Agreement.

NOVARA TRADING AG TERMS AND CONDITIONS OF SALE (February 2nd, 2021)
Gain Therapeutics, Inc.CONSULTING AGREEMENT between (January 29th, 2021)

GT Gain Therapeutics S.A, a Swiss Corporation, with registered office in Via Peri 9D, 6900 Lugano, Switzerland, registration number with the Register of Enterprises of Lugano and Tax Code CHE 438 987 642, represented herein by Mr. Lorenzo Leoni, in his capacity as President (hereinafter referred to as the "Company"),

Moreira CarlosShare Exchange Undertaking dated 6 February 2016 by and between (January 27th, 2021)
Moreira CarlosShare Exchange Agreement (January 27th, 2021)

WISeKey International Holding Ltd General-Guisan-Strasse 6, 6300 Zug, Switzerland (hereinafter the Company) (Carlos Moreira, the Exiting Class A Shareholder and the Company each a Party, and together the Parties)

Publishing Agreement for Contributions in Collected Works (January 21st, 2021)
Bioventus Inc.Contract (January 20th, 2021)

[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.

Publishing Agreement for Contributions in Collected Works (January 14th, 2021)
Network User Membership Agreement for the Usage of the Regional Booking Platform (January 14th, 2021)
Participant Agreement Between (January 12th, 2021)
Livanos Peter G.CONTROL AGREEMENT (January 11th, 2021)

This control agreement (the Control Agreement) is made as of December 31, 2020 by and between the Security Provider, the Custodian and the Secured Party.

Livanos Peter G.Security Agreement Security according to Art. 25 FISA dated as of December 31, 2020 by and between Blenheim Holdings Ltd., (the Security Provider) an exempted company, having its registered office at Clarendon House, 2 Church Street, Hamilton HM 11, ... (January 11th, 2021)
QT SaaS Terms of Service (January 7th, 2021)

This licence agreement is a legal contract between you (the Customer, You or Your) and Quadrotech Solutions AG, a company incorporated in Switzerland (registration number CHE-225.115.809) having its registered office at Alpenstrasse 15, 6302 Zug, Switzerland acting for itself and its affiliate. The term ‘affiliate’ shall mean an entity which controls, is controlled by, or is under common control with Quadrotech Solutions AG. In the event of any conflict between this agreement and the Master Service Agreement ("Master Agreement") or Statement of Work ("SOW") between Quadrotech and Customer the Master Agreement or SOW shall take precedence.

End-User License Agreement (January 6th, 2021)

This End-User License Agreement (this “Agreement”) is a legal agreement between Mirrakoi SA (“Mirrakoi”), a corporation registered in Switzerland (under UID CHE-361.911.808, address: EPFL Innovation Park, Building C, 1015 Lausanne, Switzerland), and the “Licensee”, a legal entity or natural person licensing the Software pursuant to this Agreement.

RESEARCH PROJECT AGREEMENT (January 5th, 2021)

between the Olympic Foundation for Culture and Heritage (the “Foundation”) and ..… (the “Institution”), at which …. is an employee (the “Grant Holder”) in relation to the PhD Students and Early Career Academic Research Grant Programme …… (the “Programme”), which aims to promote humanities or social sciences researches on the Olympic Movement, its history and ideals, and the impact of the Olympic Games on the various aspects of contemporary society and culture, as part of the International Olympic Committee (the “IOC”)’s missions, roles and responsibilities, as established by the Olympic Charter.

Contract (December 28th, 2020)

By using, copying, transmitting, or installing MODO, you agree to all of the terms of this License. If you do not agree to any of the terms of this License, then do not use, copy, transmit or install MODO. This is not free software. Subject to the terms below, you are hereby licensed by the licensor to use the software for evaluation purposes without charge for a period of 30 days. If you use this software after the 30 day evaluation period a registration fee is required.

GLOBAL FINANCIAL INFORMATION SERVICES SUBSCRIBER AGREEMENT (December 21st, 2020)

between Global Financial Information Services GmbH (“GFIS”), Gewerbestrasse 11, 6330 Cham, Switzerland, and the undersigned subscriber (“Subscriber”), governs the Subscriber’s subscription (“Subscription”) to any market data or other information accessible through GFIS, including bids, offers, prices, rates, other trading and informative data including information derived therefrom, distributed or made available through GFIS (collectively, “Data”).

General Terms and Conditions of Purchase (December 17th, 2020)
Mettler Toledo International Inc/Olivier A. Filliol c/o Mettler-Toledo International Inc. (December 16th, 2020)
End-User License Agreement (December 14th, 2020)

This End-User License Agreement (this “Agreement”) is a legal agreement between Mirrakoi SA (“Mirrakoi”), a corporation registered in Switzerland (under UID CHE-361.911.808, address: EPFL Innovation Park, Building C, 1015 Lausanne, Switzerland), and the “Licensee”, a legal entity or natural person licensing the Software pursuant to this Agreement.

Non-Disclosure Agreement (December 10th, 2020)